$0.3651
At close: Apr 16, 2:08 PM EDT
Comments
Loading...
Calithera Biosciences Analyst Ratings and Price Targets | OTC:CALA | Benzinga
Calithera Biosciences Inc has a consensus price target of $4 based on the ratings of 4 analysts. The high is $8 issued by HC Wainwright & Co. on August 29, 2022. The low is $2 issued by SVB Leerink on November 15, 2022. The 3 most-recent analyst ratings were released by SVB Leerink, HC Wainwright & Co., and SVB Leerink on November 15, 2022, August 29, 2022, and August 16, 2022, respectively. With an average price target of $9.33 between SVB Leerink, HC Wainwright & Co., and SVB Leerink, there's an implied 186566.67% upside for Calithera Biosciences Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
SVB Leerink
HC Wainwright & Co.
Wells Fargo
1calculated from analyst ratings
Analyst Ratings for Calithera Biosciences
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 11/15/2022 | Buy Now | — | Ladenburg Thalmann | Aydin Huseynov35% | — | Downgrade | Buy → Neutral | Get Alert |
| 11/15/2022 | Buy Now | 39900% | SVB Leerink | Jonathan Chang39% | $18 → $2 | Downgrade | Outperform → Market Perform | Get Alert |
| 08/29/2022 | Buy Now | 159900% | HC Wainwright & Co. | Swayampakula Ramakanth50% | → $8 | Upgrade | Neutral → Buy | Get Alert |
| 08/16/2022 | Buy Now | 359900% | SVB Leerink | Jonathan Chang39% | $2 → $18 | Maintains | Outperform | Get Alert |
| 05/11/2022 | Buy Now | 39900% | Wells Fargo | Nick Abbott19% | $60 → $40 | Maintains | Equal-Weight | Get Alert |
FAQ
What is the target price for Calithera Biosciences (CALA) stock?
The latest price target for Calithera Biosciences (OTCEM:CALA) was reported by Ladenburg Thalmann on November 15, 2022. The analyst firm set a price target for $0.00 expecting CALA to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Calithera Biosciences (CALA)?
The latest analyst rating for Calithera Biosciences (OTCEM:CALA) was provided by Ladenburg Thalmann, and Calithera Biosciences downgraded their neutral rating.
When was the last upgrade for Calithera Biosciences (CALA)?
The last upgrade for Calithera Biosciences Inc happened on August 29, 2022 when HC Wainwright & Co. raised their price target to $8. HC Wainwright & Co. previously had a neutral for Calithera Biosciences Inc.
When was the last downgrade for Calithera Biosciences (CALA)?
The last downgrade for Calithera Biosciences Inc happened on November 15, 2022 when Ladenburg Thalmann changed their price target from N/A to N/A for Calithera Biosciences Inc.
When is the next analyst rating going to be posted or updated for Calithera Biosciences (CALA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Calithera Biosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Calithera Biosciences was filed on November 15, 2022 so you should expect the next rating to be made available sometime around November 15, 2023.
Is the Analyst Rating Calithera Biosciences (CALA) correct?
While ratings are subjective and will change, the latest Calithera Biosciences (CALA) rating was a downgraded with a price target of $0.00 to $0.00. The current price Calithera Biosciences (CALA) is trading at is $0.01, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
